Showing results (461-470 of 26,310) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|May 5, 2022
Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compoundsReon Takeuchi, Kasumi Ogihara, Junko Fujimoto, et al.Bioorganic & Medicinal Chemistry Letters|July 23, 2022
Synthesis and evaluation of hydrazinyl-containing pyrrolo[2,3-d]pyrimidine series as potent, selective and oral JAK1 inhibitors for the treatment of rheumatoid arthritisWeiwei Mao, Hao Wu, Qiang Guo, et al.Bioorganic & Medicinal Chemistry Letters|July 14, 2022
Synthesis of a tricyclic hexapeptide -via two consecutive ruthenium-catalyzed macrocyclization steps- with a constrained topology to mimic vancomycin's binding properties toward D-Ala-D-Ala dipeptideXin Yang, Johan Kemmink, Dirk T S Rijkers, et al.Bioorganic & Medicinal Chemistry Letters|April 7, 2022
Synthesis and biological evaluation of marine natural product, Cryptoechinuline D derivatives as novel antiangiogenic agentsJia-Qi Zhu, Shu-Ran Fan, Xia Wei, et al.Bioorganic & Medicinal Chemistry Letters|April 10, 2022
Concise synthesis and preliminary biological evaluation of new triazolylthioacetone derivatives bearing pyridine, pyrazine, and 3,4,5-trimethoxybenzyl fragmentLin Chen, Bei Zhang, Yan-Hong Li, et al.Bioorganic & Medicinal Chemistry Letters|April 22, 2022
Arabinonucleic acids containing C5-propynyl modifications form stable hybrid duplexes with RNA that are efficiently degraded by E. coli RNase HAlexander Pontarelli, Christopher J WildsBioorganic & Medicinal Chemistry Letters|March 1, 2022
Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitorsAmanda Lyons, James Kirkham, Kevin Blades, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2022
Rationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studiesLalit K Golani, Md Yeunus Mian, Taukir Ahmed, et al.Bioorganic & Medicinal Chemistry Letters|April 4, 2022
Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLCThomas W Gero, David E Heppner, Tyler S Beyett, et al.Bioorganic & Medicinal Chemistry Letters|October 20, 2019
Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitorsJiming Wang, Xiangyu Zhang, Jiangkun Yan, et al.Pageof 2,631